Life Pre- and Post-IPO: The journey of iX Biopharma and ASLAN Pharmaceuticals

In this new and exciting article we capture the journey of two public-listed company – iX Biopharma and ASLAN Pharmaceuticals, listed on SGX and Nasdaq respectively in a series of questions and answers. Hear what Ms Eva Tan, Director of Corporate and Commercial Strategy at iX Biopharma and Dr. Carl Firth, founder and CEO of ASLAN Pharmaceuticals have to say about their journey going public, and how start-ups can undertake this path successfully. By Shainan Hora

What does it take for an investor to say YES?

What constitutes a good investment and what attracts investors to fund companies in the healthcare space? BCS interviewed Dr. Jessie Tong, Senior Manager at SGInnovate Venture Investing team and Dr. Koh Fong Ming, Senior Associate at Heritas Capital Management, to provide a peek into the fundraising process and to discuss insights to help start-ups in their fundraising journey. Contributed by: Shainan Hora.